Showing results (2111-2120 of 3,477) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|March 15, 2019
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the (Modern) Treatment of MelanomaHannah Yejin Kim, Parth J Upadhyay, Alia Fahmy, et al.Clinical Pharmacokinetics|April 14, 2017
Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug ClearanceIftekhar Mahmood, Million A TegengeClinical Pharmacokinetics|April 12, 2017
A Bayesian Approach for Population Pharmacokinetic Modeling of Pegylated Interferon α-2a in Hepatitis C PatientsMohammad I SalehClinical Pharmacokinetics|April 9, 2017
Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant PatientsJean-Baptiste Woillard, Jean Debord, Caroline Monchaud, et al.Clinical Pharmacokinetics|July 1, 1986
Poor correlation between single-dose data and steady-state kinetics for phenobarbitone, primidone, carbamazepine and sodium valproate in children during monotherapy. Possible reasons for the lack of correlationJ A Armijo, J L Herranz, R Arteaga, et al.Clinical Pharmacokinetics|December 10, 1997
Pharmacokinetic changes during pregnancy and their clinical relevanceR Loebstein, A Lalkin, G KorenClinical Pharmacokinetics|October 29, 1997
Clinical pharmacokinetics of stavudineK Z Rana, M N DudleyClinical Pharmacokinetics|January 1, 1997
Effect of food and gastric pH on the bioavailability of grepafloxacinC Efthymiopoulos, S L Bramer, A MaroliClinical Pharmacokinetics|January 1, 1997
Grepafloxacin pharmacokinetics in individuals with hepatic dysfunctionC Efthymiopoulos, S L Bramer, A Maroli, et al.Clinical Pharmacokinetics|January 1, 1997
Theophylline and warfarin interaction studies with grepafloxacinC Efthymiopoulos, S L Bramer, A Maroli, et al.Pageof 348